Impurity reference standards
Bosutinib impurities & reference standards
Characterised Bosutinib impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
31reference materials
1isotope-labelled
COAHPLC · NMR · MS on request
Parent API: Bosutinib WS
380843-75-4 · C26H29Cl2N5O3
![2-Cyano-N-(2,4-dichloro-5-methoxy phenyl)-3-{4-methoxy-3-[3-(4-methyl piperazin-1-yl)-propoxy]- phenylamino} acrylamide chemical structure](/media/structures/ASDUFQREKMWHMM-ISLYRVAYSA-N.svg)
2-Cyano-N-(2,4-dichloro-5-methoxy phenyl)-3-{4-methoxy-3-[3-(4-methyl piperazin-1-yl)-propoxy]- phenylamino} acrylamide
- CAS
- 846023-56-1
- Formula
- C26H31Cl2N5O4
- MW
- 548.5 g/mol
VQ-029487
2-Cyano-N-(2,4-Dichloro-5-Methoxyphenyl)Acetamide
- CAS
- 846023-24-3
- Formula
- C10H8Cl2N2O2
- MW
- 259.09 g/mol
VQ-024623
2-Cyano-N-(3,5-dichloro-4-methoxyphenyl)-acetamide
- CAS
- 1821033-10-6
- Formula
- C10H8Cl2N2O2
- MW
- 259.09 g/mol
VQ-029490
4-(2,4-Dichloro-5-methoxyphenylamino)-6,7-dimethoxyquinoline-3-carbonitrile
- CAS
- 380843-12-9
- Formula
- C19H15Cl2N3O3
- MW
- 404.2 g/mol
VQ-024626
![4-[(2,4-Dichloro-5-methoxyphenyl)amino]-7-hydroxy-6-methoxy-3-quinolinecarbonitrile chemical structure](/media/structures/YZDCJNFIBYGWGV-UHFFFAOYSA-N.svg)
4-[(2,4-Dichloro-5-methoxyphenyl)amino]-7-hydroxy-6-methoxy-3-quinolinecarbonitrile
- CAS
- 1460227-29-5
- Formula
- C18H13Cl2N3O3
- MW
- 390.2 g/mol
VQ-029485
4-Chloro-7-(3-chloropropoxy)-3-cyano-6-methoxyquinoline
- CAS
- 214470-68-5
- Formula
- C14H12Cl2N2O2
- MW
- 311.2 g/mol
VQ-029484
7-(3-Chloropropoxy)-4-(2,4-dichloro-5-methoxyanilino)-6-methoxyquinoline-3-carbonitrile
- CAS
- 380844-49-5
- Formula
- C21H18Cl3N3O3
- MW
- 466.7 g/mol
VQ-024624
Bosutinib 4-Hydroxy 7-Chloropropoxy Impurity
- CAS
- 214470-66-3
- Formula
- C14H13ClN2O3
- MW
- 292.72 g/mol
VQ-036009
N-(2-Chloro-5-methoxyphenyl)-2-cyanoacetamide
- CAS
- 1307530-78-4
- Formula
- C10H9ClN2O2
- MW
- 224.64 g/mol
VQ-036012
N-(4-Chloro-3-methoxyphenyl)-2-cyanoacetamide
- CAS
- 879644-03-8
- Formula
- C10H9ClN2O2
- MW
- 224.64 g/mol
VQ-029489
FAQs — Bosutinib impurities
Which Bosutinib impurities do you supply?
We list 31 Bosutinib-related reference materials, including process impurities, degradation products, stable-isotope-labelled standards and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Bosutinib impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Bosutinib impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Bosutinib impurity standards
We reply within one business day with price, pack options, lead time and documentation.